Baird Financial Group Inc. lifted its stake in Boston Scientific Corporation (NYSE: BSX) by 13.4% during the undefined quarter, according to the company in its most recent filing with the SEC. The fun
Boston Scientific Corporation (NYSE: BSX - Get Free Report) has received an average recommendation of "Buy" from the twenty-five analysts that are presently covering the company, MarketBeat Ratings re
Boston Scientific Corporation (BSX) Presents at Citi Annual Global Healthcare Conference 2025 Prepared Remarks Transcript
BSX accelerates growth as a wave of acquisitions boosts core portfolios and fuels expansion into high-growth adjacent markets.
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often
Alcosta Capital Management Inc. purchased a new stake in Boston Scientific Corporation (NYSE: BSX) during the undefined quarter, according to the company in its most recent disclosure with the Securit
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
BSX posts stronger Q3 margins as growth in EP and WATCHMAN lifts product mix despite tariff pressure.
Aviso Financial Inc. trimmed its holdings in shares of Boston Scientific Corporation (NYSE: BSX) by 9.4% in the second quarter, according to its most recent filing with the Securities and Exchange Com
Associated Banc Corp reduced its stake in shares of Boston Scientific Corporation (NYSE: BSX) by 0.8% in the undefined quarter, according to the company in its most recent 13F filing with the Securiti
Boston Scientific's EP breadth, WATCHMAN momentum and acquisitions give it an edge over Edwards in cardiovascular devices.
Boston Scientific (BSX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Bank Julius Baer and Co. Ltd Zurich cut its stake in shares of Boston Scientific Corporation (NYSE: BSX) by 11.4% in the second quarter, according to its most recent disclosure with the SEC. The firm
Investors with an interest in Medical - Products stocks have likely encountered both Phibro Animal Health (PAHC) and Boston Scientific (BSX). But which of these two stocks offers value investors a bet
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE